RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stress
Authors:
- Janna E. JerniganJJJanna E. Jernigan
- Hannah A. StaleyHSHannah A. Staley
- Zachary BatyZBZachary Baty
- MacKenzie L. BolenMBMacKenzie L. Bolen
- Cassandra L. ColeCCCassandra L. Cole
- Noelle K. NeighbargerNNNoelle K. Neighbarger
- Andrea R. MerchakAMAndrea R. Merchak
- Kelly B. MeneesKMKelly B. Menees
- Stephen A. CoombesSCStephen A. Coombes
Open Access
- 24 February 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 22 (1) , 1-24
Abstract
Regulator of G-protein signaling 10 (RGS10), a key homeostatic regulator of immune cells, has been implicated in multiple diseases associated with aging and chronic inflammation including Parkinson’s Disease (PD). Interestingly, subjects with idiopathic PD display reduced levels of RGS10 in subsets of peripheral immune cells. Additionally, individuals with PD have been shown to have increased activated peripheral immune cells in cerebrospinal fluid (CSF) compared to age-matched healthy controls. However, it is unknown whether peripheral immune cells in the CSF of individuals with PD also exhibit decreased levels of RGS10. Utilizing the Michael J. Fox Foundation Parkinson’s Progression Markers Initiative (PPMI) study we found that RGS10 levels are decreased in the CSF of individuals with PD compared to healthy controls and prodromal individuals. As RGS10 levels are decreased in the CSF and circulating peripheral immune cells of individuals with PD, we hypothesized that RGS10 regulates peripheral immune cell responses to chronic systemic inflammation (CSI) prior to the onset of neurodegeneration. To test this, we induced CSI for 6 weeks in C57BL6/J mice and RGS10 KO mice to assess circulating and CNS-associated immune cell responses. We found that RGS10 deficiency synergizes with CSI to induce a bias for inflammatory and cytotoxic cell populations, a reduction in antigen presentation machinery in peripheral blood immune cells, as well as in and around the brain that is most notable in males. These results highlight RGS10 as an important regulator of the systemic immune response to CSI and implicate RGS10 as a potential contributor to the development of immune dysregulation in PD.Keywords
All Related Versions
Funding Information
- The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Aligning Science Across Parkinson’s (ASAP) initiative (ASAP-020527, ASAP-020527, ASAP-020527, ASAP-020527)
- NINDS T32 Pre-Doctoral Training Program in Movement Disorders and Neurorestoration (5T32NS082168-09)
- National Institute of Health and the National Institute of Neurological Disorders and Stroke (Grant RF1NS28800)
This publication has 59 references indexed in Scilit:
- Tissue-based map of the human proteomeScience, 2015
- Critical Role of Regulator G-Protein Signaling 10 (RGS10) in Modulating Macrophage M1/M2 ActivationPLOS ONE, 2013
- Regulator of G-Protein Signaling-10 Negatively Regulates NF-κB in Microglia and Neuroprotects Dopaminergic Neurons in Hemiparkinsonian RatsThe Journal of Neuroscience, 2011
- Parkinson's disease symptoms: The patient's perspectiveMovement Disorders, 2010
- Imaging Approaches to Parkinson DiseaseJournal of Nuclear Medicine, 2010
- Effects of Acute and Chronic Inflammation on B-Cell Development and DifferentiationJournal of Investigative Dermatology, 2009
- Regulator of G-Protein Signaling 10 Promotes Dopaminergic Neuron Survival via Regulation of the Microglial Inflammatory ResponseThe Journal of Neuroscience, 2008
- Regional, cellular, and subcellular localization of RGS10 in rodent brainJournal of Comparative Neurology, 2004
- Lipopolysaccharide Stimulates the Proliferation of Human CD56+CD3− NK Cells: A Regulatory Role of Monocytes and IL-10The Journal of Immunology, 2000
- Dendritic Cell Survival and Maturation Are Regulated by Different Signaling PathwaysJournal of Experimental Medicine, 1998